Market Gains, Nordstrom Deal, Trump's Team, Zepbound Shortage Ends

  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 57 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 63%

Business Notícia

STOCK MARKET,NORDSTROM,DONALD TRUMP

The Dow Jones Industrial Average saw modest gains, while Nordstrom finalized a deal to go private. Donald Trump continues to shape his team, and the shortage of Eli Lilly's weight loss drug Zepbound has ended.

Streaming 24/7: Watch NBC 5 local news and weather for free wherever you areDow Jones Industrial Average

, meanwhile, had a smaller gain, adding just 66.69 points higher, or 0.16%. Trading was light Monday, which is expected to continue today. The market will close at 1 p.m. for the Christmas Eve holiday. Followworth roughly $6.25 billion from members of the founding Nordstrom family and the Mexican department store El Puerto de Liverpool. The family will have majority ownership of the private company, with 50.1%, while Liverpool will own 49.9%. Common shareholders, meanwhile, will receive $24.

The FDA said tirzepatide, the main ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in shortage. That means patients will likely be unable to access compounded — or cheaper, off-brand — versions of the drug that compounding pharmacies were legally allowed to make during the shortage. Six patients told CNBC that they're worried about the price of the brand-name medicine.

5 ‘very profitable' side hustles to make extra cash during the holidays—one pays up to $700 for two hours of work I interviewed over 100 parents and top researchers: The No. 1 key takeaway about raising resilient kids

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 288. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes